BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28322108)

  • 1. Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy in vitro.
    Ingallina C; Costa PM; Ghirga F; Klippstein R; Wang JT; Berardozzi S; Hodgins N; Infante P; Pollard SM; Botta B; Al-Jamal KT
    Nanomedicine (Lond); 2017 Apr; 12(7):711-728. PubMed ID: 28322108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
    Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L
    Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
    Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
    Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Biodegradable Polymeric Nanocapsules for Treatment of Malignant Tumor Using Coaxial Capillary Microfluidic Device.
    Xu Y; Hu B; Xu J; Wu J; Ye B
    Cancer Biother Radiopharm; 2020 Oct; 35(8):570-580. PubMed ID: 32196366
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
    Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
    Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
    Cosco D; Paolino D; De Angelis F; Cilurzo F; Celia C; Di Marzio L; Russo D; Tsapis N; Fattal E; Fresta M
    Eur J Pharm Biopharm; 2015 Jan; 89():30-9. PubMed ID: 25460850
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    D'Alessandro G; Quaglio D; Monaco L; Lauro C; Ghirga F; Ingallina C; De Martino M; Fucile S; Porzia A; Di Castro MA; Bellato F; Mastrotto F; Mori M; Infante P; Turano P; Salmaso S; Caliceti P; Di Marcotullio L; Botta B; Ghini V; Limatola C
    Cell Commun Signal; 2019 Aug; 17(1):108. PubMed ID: 31455353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and biological evaluation of paclitaxel loaded biodegradable PCL/PEG nanoparticles for the treatment of human neuroendocrine pancreatic tumor in mice.
    Dubey N; Shukla J; Hazari PP; Varshney R; Ganeshpurkar A; Mishra AK; Trivedi P; Bandopadhaya GP
    Hell J Nucl Med; 2012; 15(1):9-15. PubMed ID: 22413106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
    Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
    Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
    Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.
    Abellan-Pose R; Teijeiro-Valiño C; Santander-Ortega MJ; Borrajo E; Vidal A; Garcia-Fuentes M; Csaba N; Alonso MJ
    Int J Pharm; 2016 Jul; 509(1-2):107-117. PubMed ID: 27210735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents.
    Boissenot T; Fattal E; Bordat A; Houvenagel S; Valette J; Chacun H; Gueutin C; Tsapis N
    Eur J Pharm Biopharm; 2016 Nov; 108():136-144. PubMed ID: 27594209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
    Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
    Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers.
    Öztürk K; Esendağlı G; Gürbüz MU; Tülü M; Çalış S
    Int J Pharm; 2017 Jan; 517(1-2):157-167. PubMed ID: 27965135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the
    El-Sheridy NA; El-Moslemany RM; Ramadan AA; Helmy MW; El-Khordagui LK
    Drug Deliv; 2021 Dec; 28(1):906-919. PubMed ID: 33960245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-responsive nano carriers for doxorubicin delivery.
    Bagherifam S; Skjeldal FM; Griffiths G; Mælandsmo GM; Engebråten O; Nyström B; Hasirci V; Hasirci N
    Pharm Res; 2015 Apr; 32(4):1249-63. PubMed ID: 25288014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers.
    Tsvetkova Y; Beztsinna N; Baues M; Klein D; Rix A; Golombek SK; Al Rawashdeh W; Gremse F; Barz M; Koynov K; Banala S; Lederle W; Lammers T; Kiessling F
    Nano Lett; 2017 Aug; 17(8):4665-4674. PubMed ID: 28715227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.
    Daman Z; Montazeri H; Azizi M; Rezaie F; Ostad SN; Amini M; Gilani K
    Pharm Res; 2015 Nov; 32(11):3756-67. PubMed ID: 26228105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors.
    Castro A; Berois N; Malanga A; Ortega C; Oppezzo P; Pristch O; Mombrú AW; Osinaga E; Pardo H
    Int J Biol Macromol; 2021 Jul; 182():806-814. PubMed ID: 33857513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties.
    Hervella P; Alonso-Sande M; Ledo F; Lucero ML; Alonso MJ; Garcia-Fuentes M
    Curr Top Med Chem; 2014; 14(9):1115-23. PubMed ID: 24678710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.